CDRH Director Jeffrey Shuren defended an agreement with industry to double device user fees over five years, in speaking to lawmakers last week, and argued that not all fees paid by individual companies would increase by a substantial amount.
The House Energy & Commerce Health Subcommittee held its first hearing on device user fee reauthorization Feb. 15, even though FDA and industry have yet to send a proposal to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?